Drug Shortage Report for PARSITAN 50MG

Last updated on 2019-02-06 History
Report ID 71845
Drug Identification Number 01927744
Brand name PARSITAN 50MG
Common or Proper name PARSITAN
Company Name ERFA CANADA 2012 INC
Market Status MARKETED
Active Ingredient(s) ETHOPROPAZINE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N04AA
ATC description ANTICHOLINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-01-08
Actual start date 2019-01-09
Estimated end date 2019-01-23
Actual end date 2019-01-25
Shortage status Resolved
Updated date 2019-02-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1600 NOTRE DAME ST. WEST
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-02-06 French Compare
v4 2019-02-06 English Compare
v3 2019-01-10 French Compare
v2 2019-01-10 English Compare
v1 2019-01-10 English Compare

Showing 1 to 5 of 5